Clin2
NCT07085962Possibly a fitNot yet recruiting

Studying a natural supplement for liver fat in adults

Metabolic Dysfunction-associated Fatty Liver Disease

Treatments studied

Part of Digestive system, Hormones & metabolism clinical trials.

This study is testing whether a natural supplement called Calculus Bovis Sativus can improve fatty liver disease in people who have fat buildup in their liver but not significant scarring. It aims to see if the supplement is safe and effective for treating this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 18 and 75 years old.
  • You must have a diagnosis of fatty liver disease (confirmed by a special scan showing significant liver fat).
  • Your liver enzyme tests must be mildly elevated (AST and ALT between 1 and 5 times the upper normal limit).
  • You must not have significant liver scarring or cirrhosis (confirmed by one of several non-invasive tests).
  • Your weight must be stable (no more than 5% change) for at least 6 weeks before the study starts.
  • You must agree to use effective birth control during the study and for 6 months after the last dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT06891365Recruiting· Phase 1
Multiple doses of a new drug for fatty liver disease

This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.

Harrow
NCT07417124Recruiting· Phase 1
Study of SNS851 for people with high liver fat

This study tests a new medicine called SNS851 in healthy volunteers to see if it is safe and tolerable. It may help people with high liver fat, though it is not yet known if it works.

Melbourne
NCT06704321Recruiting
Effects of TOTUM-448 on liver fat and heart health

This trial tests a supplement called TOTUM-448 to see if it can reduce liver fat and improve heart health in people with a fatty liver condition (MASLD). If you have excess liver fat and are overweight, this study could help find new ways to manage your condition.

Québec, Quebec
NCT06873412Not yet recruiting
Probiotic supplement for liver health and metabolism

This trial tests whether a probiotic supplement can improve liver health and metabolism in adults with early signs of fatty liver or related conditions. It may help reduce fat in the liver and improve blood sugar and blood pressure.

NCT07025980Not yet recruiting· Phase 2
Probiotics for fatty liver disease

This study tests whether taking a probiotic supplement (a mix of helpful bacteria) can improve liver health in people with fatty liver disease linked to metabolic syndrome. It may help lower liver enzymes and reduce fat buildup in the liver.

Šibenik, Croatia

Hear when a new Metabolic Dysfunction-associated Fatty Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.